595.00DKK-2.46%Mkt Cap: 24.60M DKKP/E: —Last update: 2026-05-21
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 202…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap24.60M DKK
Enterprise Value8.89M DKK
Revenue (TTM)309.00K DKK
Gross Profit309.00K DKK
Net Income (TTM)-859.00K DKK
Revenue/Share7.408 DKK
Last Price595.00 DKK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees1
CountryDK
SectorHealthcare
IndustryBiotechnology
ISINDK0062502894
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue28.78
P/S79.62
P/B1.35
EPS (TTM)-20.98
EPS (Forward)—
52W Range
595.000% of range605.00
52W High605.00 DKK
52W Low595.00 DKK
Profitability
Gross Margin100.00%
Oper. Margin-309.06%
EBITDA Margin0.00%
Profit Margin-277.99%
ROE-4.67%
ROA-4.40%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.14M DKK
CapEx (TTM)—
FCF Margin-1492.80%
FCF Yield-18.75%
Net Debt-15.93M DKK
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio13.90
Quick Ratio13.90
Book Value/Sh440.88 DKK
Cash/Share381.79 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateDec 6, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.41.35K
Float16.78K
Insiders56.74%
Institutions5.86%
Technical
SMA 50627.04 (-5.1%)
SMA 200748.88 (-20.5%)
Beta0.14
S&P 52W Chg28.31%
Avg Vol (30d)27
Avg Vol (10d)12
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—